| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 9,500 | 8,500 | 1,000 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AIR PRODUCTS & CHEMICALS INC | 66,894 | 141,030 |
| ALBEMARLE CORP | 108,786 | 63,075 |
| ANALOG DEVICES INC | 120,169 | 428,436 |
| AUTOZONE INC | 65,043 | 148,489 |
| BIOMARIN PHARMACEUTICAL INC | 12,653 | 8,245 |
| COGNIZANT TECHNOLOGY SOLUTIONS CORP | 100,988 | 156,060 |
| DIAGEO PLC | 165,105 | 151,260 |
| DISNEY WALT CO DISNEY | 184,152 | 186,765 |
| HORMEL FOODS CORP | 127,597 | 105,875 |
| ILLINOIS TOOL WORKS INC | 62,445 | 124,375 |
| INCYTE CORP | 13,176 | 10,215 |
| IONIS PHARMACEUTICALS INC | 14,148 | 19,755 |
| JOHNSON CONTROLS INTERNATIONAL PLC | 127,013 | 317,970 |
| LINDE PLC | 73,552 | 211,131 |
| MICROSOFT CORP | 45,935 | 397,928 |
| NEUROCRINE BIOSCIENCES INC | 13,391 | 37,707 |
| NOVARTIS | 45,765 | 84,707 |
| PAYCHEX INC | 80,615 | 218,190 |
| PAYPAL HOLDINGS INC | 88,159 | 148,640 |
| PPG INDUSTRIES INC | 116,062 | 113,750 |
| PROCTER & GAMBLE CO | 86,533 | 159,320 |
| REGENERON PHARMACEUTICALS INC | 50,921 | 78,750 |
| SHELL PLC | 105,795 | 140,820 |
| STRYKER CORP | 46,573 | 158,588 |
| SYNOPSYS INC | 28,687 | 256,340 |
| TELEDYNE TECHNOLOGIES INC | 85,110 | 102,462 |
| TRIMBLE INC | 83,951 | 227,940 |
| UNILEVER PLC | 82,645 | 122,340 |
| VERISK ANALYTICS INC | 64,602 | 249,200 |
| VERTEX PHARMACEUTICALS INC | 12,251 | 66,780 |
| WEYERHAEUSER CO | 99,566 | 77,070 |
| GENMAB | 18,250 | 10,330 |
| ALPHABET INC | 173,868 | 176,230 |
| EXACT SCIENCES CORP | 30,474 | 37,198 |
| GE HEALTHCARE TECHNOLOGIES INC | 73,360 | 74,070 |
| METTLER-TOLEDO INTERNATIONAL INC | 70,448 | 58,736 |
| ROCKWELL AUTOMATION INC | 102,750 | 132,868 |
| ALNYLAM PHARMACEUTICALS INC | 10,105 | 13,044 |
| APPLIED MATERIALS INC | 138,925 | 183,070 |
| AUTODESK INC | 145,880 | 154,785 |
| EXELXIS INC | 10,939 | 13,223 |
| INTELLIA THERAPEUTICS INC | 10,972 | 6,566 |
| IOVANCE BIOTHERAPEUTICS INC | 9,290 | 1,720 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT MANAGEMENT FEES | 38,692 | 38,692 | 0 | |
| BANK CUSTODIAL FEES | 3,869 | 3,869 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXCISE TAXES | 7,298 | 0 | 0 | |
| FOREIGN TAXES | 545 | 545 | 0 |